首页 | 本学科首页   官方微博 | 高级检索  
检索        

急性心力衰竭诊断和治疗展望
引用本文:白玲,马爱群.急性心力衰竭诊断和治疗展望[J].心血管病学进展,2011,32(4):465-469.
作者姓名:白玲  马爱群
作者单位:西安交通大学医学院第一附属医院心内科,陕西,西安,710061
摘    要:心力衰竭作为心血管事件链的下游是21世纪心血管疾病治疗的最后战场,急性心力衰竭常危及生命,必须紧急施救和治疗。N端-脑钠肽前体是鉴别急性心力衰竭与其他原因所致呼吸困难的重要指标,和超敏C反应蛋白、肌钙蛋白与急性心力衰竭的程度、预后密切相关。奈西立肽、左西孟旦、托伐普坦、rolofylline等为急性心力衰竭的药物治疗带来前景,急性心力衰竭的非药物治疗将成为药物治疗的有效伴随手段。全方位多层次的防治是降低急性心力衰竭再住院率、病死率的重要方式。

关 键 词:急性心力衰竭  诊断  治疗  展望

Prospection of Diagnosis and Treatment of Acute Heart Failure
BAI Ling,MA Ai-qun.Prospection of Diagnosis and Treatment of Acute Heart Failure[J].Advances in Cardiovascular Diseases,2011,32(4):465-469.
Authors:BAI Ling  MA Ai-qun
Institution:BAI Ling MA Ai-qun (Department of Cardiology,The First Affiliated Hospital of Medical College of Xi'an Jiaotong University,Xi'an 710061,Shanxi,China)
Abstract:Heart failure which acts as the end of cardiovascular chain is eventual battlefield of cardiovascular treatment.Acute heart failure(AHF) endangers life and need to be treated urgently.N-terminal pro-brain natriuretic peptide(NT-proBNP) is important in distinguishing dyspnea from AHF and others.There are relationship between NT-proBNP and a high-sensitivity C reactive protein,cardiac troponin and the prognosis.The novel therapies including nesiritide,levosimedan,tolvaptan,and rolofylline offer hope for thera...
Keywords:acute heart failure  diagnosis  therapy  prospection  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号